Twenty-three months is the outside limit of a residency at Agoranov, which is longer than most accelerator places and reflects what it is built for: research spin-offs and science-led companies in biotech and deep tech, where the road to a product is measured in years rather than quarters.
The incubator is publicly backed and based in Paris. It writes no cheque of its own. What it provides is the residency, coaching, and access to a pipeline of non-dilutive grants, and it takes no equity for any of it.
Entry is rolling rather than by cohort.
What it actually costs you
Agoranov is a publicly backed Paris incubator built around research spin-offs and science-led companies in biotech and deep tech. Residency runs up to 23 months and comes with coaching and access to a non-dilutive grant pipeline; there is no direct cheque and no equity is taken, so founders keep their cap table intact. Intake is rolling rather than cohort-based.